AMP recognizes Michael Laposata as Champion for Innovation
Michael Laposata, M.D., Ph.D., receives the AMP Champion for Innovation Award for his advocacy against FDA's LDT rule and his significant contributions to clinical laboratory medicine, including academic leadership and research.
The Association chose Dr. Laposata as their honoree for stepping up as joint plaintiff in their lawsuit against the U.S. Food and Drug Administration (FDA) regarding the laboratory-developed test (LDT) rule. His efforts led to the FDA rule being vacated earlier this year. Dr. Laposata’s many other achievements in the clinical laboratory field were also contributing factors.
Dr. Laposata’s bio, according to AMP: Previously recognized by The Pathologist as the most influential pathologist in the United States, Laposata is a professor and the former chair of the Department of Pathology and the director of the M.D.–Ph.D. program at the University of Texas Medical Branch at Galveston. He is the author of Laposata’s Laboratory Medicine, now in its fourth edition. During his career, Laposata has published more than 200 peer-reviewed articles and received 14 major teaching awards at Harvard University, Massachusetts General Hospital and the University of Pennsylvania School of Medicine. He earned his M.D. and Ph.D. from Johns Hopkins University and completed a fellowship and residency in laboratory medicine at Washington University School of Medicine.
AMP will present the award to Dr. Laposata at their annual meeting.
